UB17:LSE:LSE-UBS MSCI EMU Value UCITS EUR Adis (GBX)

ETF | Others |

Last Closing

USD 4209

Change

-4.00 (-0.09)%

Market Cap

N/A

Volume

1.14K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+13.40 (+7.84%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.01 (-0.04%)

USD 640.06B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.01 (+0.04%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

+1.60 (+1.54%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-1.10 (-1.48%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.01 (-0.04%)

USD 259.48B
0QZO:LSE 0QZO

+3.90 (+4.55%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

+1.30 (+0.91%)

USD 202.26B
0R24:LSE Intel Corp.

+1.51 (+7.71%)

USD 196.14B

ETFs Containing UB17:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.54% 94% A 88% B+
Dividend Return 0.01% 23% F 18% F
Total Return 14.55% 94% A 88% B+
Trailing 12 Months  
Capital Gain 9.73% 79% B- 74% C
Dividend Return 0.04% 29% F 25% F
Total Return 9.77% 77% C+ 72% C
Trailing 5 Years  
Capital Gain 80.30% 74% C 77% C+
Dividend Return 0.25% 39% F 47% F
Total Return 80.54% 72% C 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 8.16% 58% F 63% D
Dividend Return 8.16% 57% F 62% D
Total Return 0.01% 20% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) 11.57% 58% F 75% C
Risk Adjusted Return 70.52% 70% C- 81% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.